FDA Seeks Nominations for Members to Serve on the Tobacco Products Scientific Advisory Committee

August 15, 2016

FDA Seeks Nominations for Individuals to Serve on Tobacco Products Scientific Advisory Committee

On Monday, August 15th, FDA issued a notice requesting nominations for a nonvoting member to serve on the Tobacco Products Scientific Advisory Committee to represent the interests of tobacco growers.  In addition, FDA is also seeking a nominee to act as an alternate to this representative.

FDA states that any organization interested in participating in the selection of this nonvoting member should notify the Agency in writing by September 14, 2016.  The nominee may be “self-nominated or nominated by an organization to serve as a nonvoting industry representative.”

Tobacco Products Scientific Advisory Committee

The role of the Tobacco Products Scientific Advisory Committee is to guide the FDA Commissioner.  “The Committee reviews and evaluates safety, dependence, and health issues relating to tobacco products and provides appropriate advice, information, and recommendations to the Commissioner.”

Application Procedure

FDA’s notice states that nominations will only be accepted for positions that are vacant as of the publication date of the Agency’s notice.  Contact information, current curriculum vitae (CV), and the name of the committee of interest should be sent to the FDA Advisory Committee Membership Nomination Portal by September 14, 2016.

In addition, FDA states that it “seeks to include the views of women, and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore encourages nominations of appropriately qualified candidates from these groups.”

TAGS:

March 24, 2017

510(k) Database Enables Sponsors to Search for Substantially Equivalent Medical Devices

Sponsors no longer have to rely on checking lists of 510(k) devices when looking to make a substantial equivalence claim. While the FDA does release an updated list each month, Sponsors can save time...

September 16, 2015

FDA Takes Genomic Testing a Step Further with Regulatory Strategies & Public Workshops

FDA has announced plans to develop diagnostic systems for the use of next generation sequencing (NGS) technologies, furthering the Precision Medicine Initiative (PMI) ordered by President Obama. The...

March 15, 2019

FDA Announces Update to Nonproprietary Naming Convention for Biosimilar Products

On Thursday, March 7th, FDA published a revised draft guidance, updating its nonproprietary naming convention for biological products licensed under section 351 of the Public Health Service Act (PHS...